Abstract:Paradoxically, aggregation of specific proteins is characteristic of many human diseases and aging, yet aggregates have increasingly been found to be unnecessary for initiating pathogenesis. Here we determined the NMR topology and dynamics of a helical mutant in a membrane environment transformed from the 125-residue cytosolic all-β MSP domain of vesicle-associated membrane protein-associated protein B (VAPB) by the ALS-causing P56S mutation. Despite its low hydrophobicity, the P56S major sperm protein (MSP) domain becomes largely embedded in the membrane environment with high backbone rigidity. Furthermore it is composed of five helices with amphiphilicity comparable to those of the partly-soluble membrane toxin mellitin and α-synuclein causing Parkinson's disease. Consequently, the mechanism underlying this chameleon transformation becomes clear: by disrupting the specific tertiary interaction network stabilizing the native all-β MSP fold to release previously-locked amphiphilic segments, the P56S mutation acts to convert the classic MSP fold into a membrane-active protein that is fundamentally indistinguishable from mellitin and α-synuclein which are disordered in aqueous solution but spontaneously partition into membrane interfaces driven by hydrogen-bond energetics gained from forming α-helix in the membrane environments. As segments with high amphiphilicity exist in all proteins, our study successfully resolves the paradox by deciphering that the proteins with a higher tendency to aggregate have a stronger potential to partition into membranes through the same mechanism as α-synuclein to initially attack membranes to trigger pathogenesis without needing aggregates. This might represent the common first step for various kinds of aggregated proteins to trigger familiar, sporadic and aging diseases. Therefore the homeostasis of aggregated proteins in vivo is the central factor responsible for a variety of human diseases including aging. The number and degree of the membrane attacks by aggregated proteins may act as an endogenous clock to count down the aging process. Consequently, a key approach to fight against them is to develop strategies and agents to maintain or even enhance the functions of the degradation machineries.

Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition

Transcellular transmission and molecular heterogeneity of aggregation-prone proteins in neurodegenerative diseases

Protein Aggregation: Opposing Effects of Chaperones and Crowding

Temporal control of acute protein aggregate turnover by UBE3C and NRF1-dependent proteasomal pathways

Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception

TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport

Molecular insights into aggrephagy: Their cellular functions in the context of neurodegenerative diseases

Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity

Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders

Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases

Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components

Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications

Cytoplasmic localization of amyotrophic lateral sclerosis‐related TDP‐43 proteins modulates stress granule formation

Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranes

Clearance of protein aggregates during cell division

Autophagy preferentially degrades non-fibrillar polyQ aggregates

Anti-aggregate activity